Quest Total Stockholder Equity from 2010 to 2024

DGX Stock  USD 163.59  0.30  0.18%   
Quest Diagnostics Total Stockholder Equity yearly trend continues to be fairly stable with very little volatility. Total Stockholder Equity will likely drop to about 3.9 B in 2024. Total Stockholder Equity is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. View All Fundamentals
 
Total Stockholder Equity  
First Reported
1996-09-30
Previous Quarter
6.6 B
Current Value
6.8 B
Quarterly Volatility
1.9 B
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Quest Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quest Diagnostics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 265.1 M, Interest Expense of 99.3 M or Selling General Administrative of 1.5 B, as well as many indicators such as Price To Sales Ratio of 1.13, Dividend Yield of 0.0214 or PTB Ratio of 3.0. Quest financial statements analysis is a perfect complement when working with Quest Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Quest Diagnostics Correlation against competitors.

Latest Quest Diagnostics' Total Stockholder Equity Growth Pattern

Below is the plot of the Total Stockholder Equity of Quest Diagnostics Incorporated over the last few years. It is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Quest Diagnostics' Total Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Quest Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Total Stockholder Equity10 Years Trend
Slightly volatile
   Total Stockholder Equity   
       Timeline  

Quest Total Stockholder Equity Regression Statistics

Arithmetic Mean4,734,186,211
Geometric Mean4,260,847,515
Coefficient Of Variation32.18
Mean Deviation1,072,226,203
Median4,684,000,000
Standard Deviation1,523,565,670
Sample Variance2321252.4T
Range6.2B
R-Value0.71
Mean Square Error1246030.8T
R-Squared0.50
Significance0
Slope241,269,951
Total Sum of Squares32497532.9T

Quest Total Stockholder Equity History

20243.9 B
20236.3 B
20225.9 B
20216.4 B
20206.8 B
20195.6 B
20185.2 B

About Quest Diagnostics Financial Statements

Quest Diagnostics investors use historical fundamental indicators, such as Quest Diagnostics' Total Stockholder Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Quest Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Stockholder Equity6.3 B3.9 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Quest Stock Analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.